Literature DB >> 31970188

Value of dynamic plasma cell-free DNA monitoring in septic shock syndrome: A case report.

Jing-Ping Liu1, Shi-Chang Zhang1, Shi-Yang Pan2.   

Abstract

BACKGROUND: Mortality due to septic shock is relatively high. The dynamic monitoring of plasma cell-free DNA (cfDNA) can guide the treatment of septic shock. CASE
SUMMARY: Herein, we present a typical case of septic shock syndrome caused by the bacilli Acinetobacter baumannii and Pantoea. The patient complained of abdominal pain, fever and chills upon admission to the Emergency Department. Marked decreases in white blood cells and procalcitonin (PCT) were observed after the patient received continuous renal replacement and extracorporeal membrane oxygenation. Plasma cfDNA levels were consistently high, peaking at 1366.40 ng/mL, as measured by a duplex real-time PCR assay with an internal control, which was developed as a novel method for the accurate quantification of cfDNA. The patient died of septic shock on HD 8, suggesting that cfDNA could be used to monitor disease progression more effectively than PCT and the other inflammatory factors measured in this case.
CONCLUSION: CfDNA may be a promising marker that complements other inflammatory factors to monitor disease progression in patients with septic shock. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Acinetobacter baumannii; Case report; Cell-free DNA; Septic shock

Year:  2020        PMID: 31970188      PMCID: PMC6962064          DOI: 10.12998/wjcc.v8.i1.200

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  21 in total

Review 1.  Physiology and genetics of procalcitonin.

Authors:  P Maruna; K Nedelníková; R Gürlich
Journal:  Physiol Res       Date:  2000       Impact factor: 1.881

2.  [Not Available].

Authors:  P MANDEL; P METAIS
Journal:  C R Seances Soc Biol Fil       Date:  1948-02

3.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

4.  Evaluation and comparison of in vitro degradation kinetics of DNA in serum, urine and saliva: A qualitative study.

Authors:  Wang Yao; Chen Mei; Xiao Nan; Liu Hui
Journal:  Gene       Date:  2016-06-16       Impact factor: 3.688

5.  Cell Free DNA and Procalcitonin as Early Markers of Complications in ICU Patients with Multiple Trauma and Major Surgery.

Authors:  Asmaa I Ahmed; Randa A Soliman; Shereif Samir
Journal:  Clin Lab       Date:  2016-12-01       Impact factor: 1.138

6.  Circulating mutant DNA to assess tumor dynamics.

Authors:  Frank Diehl; Kerstin Schmidt; Michael A Choti; Katharine Romans; Steven Goodman; Meng Li; Katherine Thornton; Nishant Agrawal; Lori Sokoll; Steve A Szabo; Kenneth W Kinzler; Bert Vogelstein; Luis A Diaz
Journal:  Nat Med       Date:  2007-07-31       Impact factor: 53.440

Review 7.  Extracorporeal blood purification in sepsis and sepsis-related acute kidney injury.

Authors:  Andrew A House; Claudio Ronco
Journal:  Blood Purif       Date:  2008-01-10       Impact factor: 2.614

8.  Comparison of procalcitonin and C-reactive protein as markers of sepsis.

Authors:  Aldo Luzzani; Enrico Polati; Romolo Dorizzi; Alessio Rungatscher; Raffaella Pavan; Alberto Merlini
Journal:  Crit Care Med       Date:  2003-06       Impact factor: 7.598

9.  Development and Evaluation of a Duplex Real-Time PCR Assay With a Novel Internal Standard for Precise Quantification of Plasma DNA.

Authors:  Dan Chen; Shiyang Pan; Erfu Xie; Li Gao; Huaguo Xu; Wenying Xia; Ting Xu; Peijun Huang
Journal:  Ann Lab Med       Date:  2017-01       Impact factor: 3.464

10.  Real-time monitoring efficiency and toxicity of chemotherapy in patients with advanced lung cancer.

Authors:  Hong Wang; Bingfeng Zhang; Dan Chen; Wenying Xia; Jiexin Zhang; Fang Wang; Jian Xu; Yan Zhang; Meijuan Zhang; Lixia Zhang; Yachun Lu; Yan Geng; Peijun Huang; Puwen Huang; Hong Wang; Shiyang Pan
Journal:  Clin Epigenetics       Date:  2015-11-05       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.